Ir al contenido
· Biorrevitalización
SKU 11210

Viscoderm 0.8

En stock
Volumen
3 x 1 mL
Laboratorio
IBSA
Origen
Italia
Indicación
Biorevitalisation, dry and thin skin, fine lines
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.

Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified personnel. Its highly purified sodium hyaluronate is obtained by fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1 ml pre-filled syringe contains 8 mg of it.

Principales ventajas de Viscoderm 0.8

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for slight xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
Información clave
Marca Viscoderm
Fabricante IBSA
País de origen Italy
Certificación CE-marked medical device for intradermal use, CE 0477
Composición Per 1 ml syringe: sodium hyaluronate 8.000 mg; sodium chloride 8.500 mg; sodium phosphate 0.205 mg; water for injection q.s. 1.0 ml
Volumen / Tamaño 1 ml per syringe, 3 ml per pack
Envase 3 pre-filled syringes x 1 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
Tamaño de la aguja 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
Tipo de uso Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
Profundidad de inyección Intradermal, at medium-deep level, using a linear or picotage technique
Protocolo / Duración Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

Indicaciones y uso profesional

Indicaciones principales

  • Slight xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Uso profesional

Viscoderm 0.8 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Zonas de tratamiento

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

Perfil del paciente

Viscoderm 0.8 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 0.8% concentration is indicated to counteract slight xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Cómo funciona Viscoderm 0.8 ​

Viscoderm 0.8 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 0.8% concentration is the lowest of the three in the range and is the one indicated for slight xerodermia.

Por qué comprar en Allpara

Allpara ofrece productos VISCODERM originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

/ Especificaciones

La ficha técnica

Categoría
Biorrevitalización
Marca
VISCODERM
Laboratorio
IBSA
SKU
11210
Formato
3 x 1 mL
Origen
Italia
Indicación
Biorevitalisation, dry and thin skin, fine lines
Uso
Injectable gel implant, professional use
/ Detalles del producto

El expediente completo

Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified personnel. Its highly purified sodium hyaluronate is obtained by fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1 ml pre-filled syringe contains 8 mg of it.

IBSA, país de origen Italia.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?
The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
Is the hyaluronic acid in Viscoderm 0.8 chemically modified?
No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.
Who should not be treated with Viscoderm 0.8?
Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.
/ FAQ

Preguntas frecuentes

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.
Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

Más productos de IBSA

Ver laboratorio

Alternativas para la clínica

Todos los productos

Viscoderm 0.8

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified personnel. Its highly purified sodium hyaluronate is obtained by fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1 ml pre-filled syringe contains 8 mg of it.

Principales ventajas de Viscoderm 0.8

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for slight xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
Información clave
Marca Viscoderm
Fabricante IBSA
País de origen Italy
Certificación CE-marked medical device for intradermal use, CE 0477
Composición Per 1 ml syringe: sodium hyaluronate 8.000 mg; sodium chloride 8.500 mg; sodium phosphate 0.205 mg; water for injection q.s. 1.0 ml
Volumen / Tamaño 1 ml per syringe, 3 ml per pack
Envase 3 pre-filled syringes x 1 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
Tamaño de la aguja 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
Tipo de uso Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
Profundidad de inyección Intradermal, at medium-deep level, using a linear or picotage technique
Protocolo / Duración Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

Indicaciones y uso profesional

Indicaciones principales

  • Slight xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Uso profesional

Viscoderm 0.8 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Zonas de tratamiento

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

Perfil del paciente

Viscoderm 0.8 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 0.8% concentration is indicated to counteract slight xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Cómo funciona Viscoderm 0.8 ​

Viscoderm 0.8 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 0.8% concentration is the lowest of the three in the range and is the one indicated for slight xerodermia.

Por qué comprar en Allpara

Allpara ofrece productos VISCODERM originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

Más productos de IBSA

Ver el laboratorio →

Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified personnel. Its highly purified sodium hyaluronate is obtained by fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1 ml pre-filled syringe contains 8 mg of it.

IBSA, país de origen Italia.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.